Literature DB >> 2715720

Studies on oxidized low density lipoproteins. Controlled oxidation and a prostaglandin artifact.

H F Zhang1, W B Davis, X S Chen, R L Whisler, D G Cornwell.   

Abstract

Low density lipoproteins (LDL), isolated by ultracentrifugal flotation, were oxidized (LDLOXID) slowly during dialysis against 0.15 M NaCl and subsequent incubation in 96% air-4% CO2 at 37 degrees C. Butylated hydroxytoluene prevented LDL oxidation. LDL preparations from different sera were oxidized at different rates and the degree of lipid peroxidation was controlled by varying the incubation time. Mild oxidation did not alter the electrophoretic mobility of the LDLOXID preparations. LDLOXID contained lipid peroxides in neutral lipids, had increased amounts of lysophosphatidylcholine, and contained a number of complex oxidation products that were generated from the oxidation of free fatty acids. These oxidation products included large amounts of soluble material that cross-reacted with antibodies to PGE2 but not 6-keto-PGF1 alpha. The amount of cross-reacting material was proportional to the degree of lipid peroxidation. Cross-reacting material in LDLOXID preparations was evidently formed from the oxidation of free fatty acids released from LDL, since cross-reacting material was also formed when a synthetic fat emulsion was oxidized in the presence of free arachidonic acid.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2715720

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  2 in total

1.  Activation of human blood monocytes by oxidized polyunsaturated fatty acids: a possible mechanism for the generation of lipid peroxides in the circulation.

Authors:  P Görög
Journal:  Int J Exp Pathol       Date:  1991-04       Impact factor: 1.925

2.  Action of bradykinin at the cyclooxygenase step in prostanoid synthesis through the arachidonic acid cascade.

Authors:  H Zhang; T S Gaginella; X Chen; D G Cornwell
Journal:  Agents Actions       Date:  1991-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.